PMID- 30762815
OWN - NLM
STAT- MEDLINE
DCOM- 20190314
LR  - 20221005
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Print)
IS  - 0025-7974 (Linking)
VI  - 98
IP  - 7
DP  - 2019 Feb
TI  - Electrical stimulation on adverse events caused by chemotherapy in patients with 
      cervical cancer: A protocol for a systematic review of randomized controlled 
      trial.
PG  - e14609
LID - 10.1097/MD.0000000000014609 [doi]
LID - e14609
AB  - BACKGROUND: This protocol of systematic review aims to investigate the 
      effectiveness of electrical stimulation (ES) on adverse events (AEs) caused by 
      chemotherapy in patients with cervical cancer (CC). METHODS: This systematic 
      review of randomized controlled trials will be identified through searchers of 
      PUBMED, PsycINFO, Scopus, Opengrey, Cochrane Central Register of Controlled 
      Trials, EMBASE, Cumulative Index to Nursing and Allied Health Literature, Web of 
      Science, Allied and Complementary Medicine Database, and Chinese Biomedical 
      Literature Database. All the sources will be searched from the inception to the 
      date of study search ran. Additionally, websites of clinical trials registry and 
      reference lists provided in relevant studies and reviews will also be searched. 
      Two independent reviewers will evaluate the eligibility criteria of all potential 
      literature, extract the data, and determine the risk of bias for each included 
      study. RevMan 5.3 software will be used to pool the data and to conduct a 
      meta-analysis. RESULTS: This systematic review will assess the effectiveness of 
      ES on AEs caused by chemotherapy in patients with CC. CONCLUSION: The findings of 
      this study may summarize the latest evidence for the ES on AEs following 
      chemotherapy for CC. PROSPERO REGISTRATION NUMBER: PROSPERO CRD42019120191.
FAU - Dou, Peng-Hui
AU  - Dou PH
AD  - Department of Radiotherapy and Chemotherapy.
FAU - Zhang, Dan-Feng
AU  - Zhang DF
AD  - Department of Gynecology.
FAU - Su, Cui-Hong
AU  - Su CH
AD  - Department of Gynecology.
FAU - Zhang, Xiao-Li
AU  - Zhang XL
AD  - Department of Scientific Research, First Affiliated Hospital of Jiamusi 
      University, Jiamusi, China.
FAU - Wu, Ying-Jie
AU  - Wu YJ
AD  - Department of Gynecology.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - Antineoplastic Agents/*adverse effects/therapeutic use
MH  - Diarrhea/chemically induced/therapy
MH  - Electric Stimulation Therapy/*methods
MH  - Fatigue/chemically induced/therapy
MH  - Female
MH  - Humans
MH  - Nausea/chemically induced/therapy
MH  - Pain/chemically induced
MH  - Randomized Controlled Trials as Topic
MH  - Research Design
MH  - Uterine Cervical Neoplasms/*drug therapy
MH  - Vomiting/chemically induced/therapy
PMC - PMC6408053
COIS- The authors have no conflicts of interest to disclose.
EDAT- 2019/02/15 06:00
MHDA- 2019/03/15 06:00
PMCR- 2019/02/15
CRDT- 2019/02/15 06:00
PHST- 2019/02/15 06:00 [entrez]
PHST- 2019/02/15 06:00 [pubmed]
PHST- 2019/03/15 06:00 [medline]
PHST- 2019/02/15 00:00 [pmc-release]
AID - 00005792-201902150-00092 [pii]
AID - MD-D-19-00771 [pii]
AID - 10.1097/MD.0000000000014609 [doi]
PST - ppublish
SO  - Medicine (Baltimore). 2019 Feb;98(7):e14609. doi: 10.1097/MD.0000000000014609.